Impact BioMedical

Yahoo Finance • 30 days ago

Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans

HOUSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO) announced that its annual report(10-K) for the fiscal year ending December 31, 2025, filed on March 11, 2026, includes an audit opinion from Grassi &... Full story

Yahoo Finance • 2 months ago

Omnicell, Inc. (OMCL): A Bull Case Theory

We came across a bullish thesis on Omnicell, Inc. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on OMCL. Omnicell, Inc.'s share was trading at $38.61 as of February 18th. OMCL’s trailing P/E was 9... Full story

Yahoo Finance • 8 months ago

Impact Biomedical announces 3F US patent issue

* Impact Biomedical (NYSE:IBO [https://seekingalpha.com/symbol/IBO]) announced on Monday that the US Patent and Trademark Office has issued a patent titled “Composition and Method of Controlling Infectious Diseases with Functional Fragra... Full story